Geoffrey Kuesters Selected Research

Drug Therapy (Chemotherapy)

1/2019

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geoffrey Kuesters Research Topics

Disease

4	Multiple Sclerosis 10/2017 - 10/2014
3	Neoplasms (Cancer) 11/2020 - 01/2019
2	Relapsing-Remitting Multiple Sclerosis 06/2017 - 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Adenocarcinoma 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Body Weight (Weight, Body) 01/2017

Drug/Important Bio-Agent (IBA)

3	Natalizumab (Tysabri)FDA Link 10/2017 - 01/2017
2	histidine-rich proteinsIBA 11/2020 - 01/2019
2	seribantumabIBA 11/2020 - 01/2019
1	Hormones (Hormone)IBA 11/2020
1	Neuregulin-1 (Neuregulin 1)IBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	AntibodiesIBA 01/2017
1	IntegrinsIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	BuffersIBA 10/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2014

Therapy/Procedure

3	Therapeutics 01/2021 - 10/2017
1	Drug Therapy (Chemotherapy) 01/2019